Strategy of antibody-drug conjugates in  preclinical safety evaluation

HONG Min， ZHAO Xiao-ping， MA Jing

PDF(549 KB)
Chinese Journal of Pharmacology and Toxicology
PDF(549 KB)
Chinese Journal of Pharmacology and Toxicology ›› 2016, Vol. 30 ›› Issue (1) : 7-12. DOI: 10.3867/j.issn.1000-3002.2016.01.002
FRONTIER VIEWS

Strategy of antibody-drug conjugates in  preclinical safety evaluation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2016, 30(1): 7-12 https://doi.org/10.3867/j.issn.1000-3002.2016.01.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(549 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉